Strategies for Optimizing Adherence to Highly Active Antiretroviral Therapy: Lessons from Research and Clinical Practice
Open Access
- 15 September 2001
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (6), 865-872
- https://doi.org/10.1086/322698
Abstract
Successful treatment of human immunodeficiency virus infection/acquired immunodeficiency syndrome (HIV/AIDS) with highly active antiretroviral therapKeywords
This publication has 24 references indexed in Scilit:
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000
- Adherence to Triple Therapy and Viral Load ResponseJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent populationAIDS, 2000
- Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens.JAMA, 2000
- Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug ReactionsAnnals of Internal Medicine, 1999
- The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic responseAIDS, 1999
- HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapyAIDS, 1999
- HIV/AIDS patients’ perspectives on adhering to regimens containing protease inhibitorsJournal of General Internal Medicine, 1998
- Public Health Implications of Antiretroviral Therapy and HIV Drug ResistanceJAMA, 1998
- Patient compliance and medical researchJournal of General Internal Medicine, 1994